nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CYP1A1—Dacarbazine—skin cancer	0.352	1	CbGbCtD
Dicyclomine—Constipation—Vismodegib—skin cancer	0.00431	0.00675	CcSEcCtD
Dicyclomine—Erectile dysfunction—Imiquimod—skin cancer	0.0043	0.00673	CcSEcCtD
Dicyclomine—Disorientation—Bleomycin—skin cancer	0.00429	0.00672	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Vismodegib—skin cancer	0.00412	0.00645	CcSEcCtD
Dicyclomine—CHRM3—muscle of abdomen—skin cancer	0.00412	0.444	CbGeAlD
Dicyclomine—Eye disorder—Vemurafenib—skin cancer	0.00409	0.00641	CcSEcCtD
Dicyclomine—Cardiac disorder—Vemurafenib—skin cancer	0.00406	0.00637	CcSEcCtD
Dicyclomine—Dermatitis atopic—Docetaxel—skin cancer	0.004	0.00627	CcSEcCtD
Dicyclomine—Abdominal pain—Vismodegib—skin cancer	0.00398	0.00624	CcSEcCtD
Dicyclomine—Mediastinal disorder—Vemurafenib—skin cancer	0.00395	0.00618	CcSEcCtD
Dicyclomine—Erythema—Vemurafenib—skin cancer	0.00381	0.00597	CcSEcCtD
Dicyclomine—Necrosis—Docetaxel—skin cancer	0.00378	0.00591	CcSEcCtD
Dicyclomine—Thrombophlebitis—Temozolomide—skin cancer	0.00374	0.00585	CcSEcCtD
Dicyclomine—Ageusia—Docetaxel—skin cancer	0.00366	0.00573	CcSEcCtD
Dicyclomine—Lethargy—Dactinomycin—skin cancer	0.00365	0.00572	CcSEcCtD
Dicyclomine—Asthenia—Vismodegib—skin cancer	0.00361	0.00566	CcSEcCtD
Dicyclomine—Pruritus—Vismodegib—skin cancer	0.00356	0.00558	CcSEcCtD
Dicyclomine—Nasal congestion—Temozolomide—skin cancer	0.00355	0.00556	CcSEcCtD
Dicyclomine—Eye disorder—Imiquimod—skin cancer	0.00349	0.00547	CcSEcCtD
Dicyclomine—Thrombophlebitis—Fluorouracil—skin cancer	0.00344	0.00539	CcSEcCtD
Dicyclomine—Amnesia—Temozolomide—skin cancer	0.00344	0.00539	CcSEcCtD
Dicyclomine—Immune system disorder—Imiquimod—skin cancer	0.00337	0.00528	CcSEcCtD
Dicyclomine—Mediastinal disorder—Imiquimod—skin cancer	0.00337	0.00527	CcSEcCtD
Dicyclomine—Disorientation—Fluorouracil—skin cancer	0.00333	0.00522	CcSEcCtD
Dicyclomine—Mental disorder—Imiquimod—skin cancer	0.00327	0.00513	CcSEcCtD
Dicyclomine—Erythema—Imiquimod—skin cancer	0.00325	0.00509	CcSEcCtD
Dicyclomine—Diplopia—Temozolomide—skin cancer	0.00324	0.00507	CcSEcCtD
Dicyclomine—Vomiting—Vismodegib—skin cancer	0.0032	0.00502	CcSEcCtD
Dicyclomine—Affect lability—Temozolomide—skin cancer	0.00318	0.00499	CcSEcCtD
Dicyclomine—Rash—Vismodegib—skin cancer	0.00318	0.00497	CcSEcCtD
Dicyclomine—Amnesia—Fluorouracil—skin cancer	0.00317	0.00497	CcSEcCtD
Dicyclomine—Dermatitis—Vismodegib—skin cancer	0.00317	0.00497	CcSEcCtD
Dicyclomine—Face oedema—Temozolomide—skin cancer	0.00312	0.00489	CcSEcCtD
Dicyclomine—Anaphylactic shock—Vemurafenib—skin cancer	0.00311	0.00487	CcSEcCtD
Dicyclomine—Mood swings—Temozolomide—skin cancer	0.00306	0.0048	CcSEcCtD
Dicyclomine—Nervous system disorder—Vemurafenib—skin cancer	0.00305	0.00478	CcSEcCtD
Dicyclomine—Lethargy—Fluorouracil—skin cancer	0.00304	0.00476	CcSEcCtD
Dicyclomine—Ill-defined disorder—Imiquimod—skin cancer	0.00302	0.00472	CcSEcCtD
Dicyclomine—Nausea—Vismodegib—skin cancer	0.00299	0.00469	CcSEcCtD
Dicyclomine—Agitation—Imiquimod—skin cancer	0.00299	0.00468	CcSEcCtD
Dicyclomine—Angioedema—Imiquimod—skin cancer	0.00297	0.00465	CcSEcCtD
Dicyclomine—Injection site reaction—Docetaxel—skin cancer	0.00295	0.00462	CcSEcCtD
Dicyclomine—Malaise—Imiquimod—skin cancer	0.00293	0.00459	CcSEcCtD
Dicyclomine—Breast disorder—Temozolomide—skin cancer	0.00292	0.00458	CcSEcCtD
Dicyclomine—Syncope—Imiquimod—skin cancer	0.00292	0.00457	CcSEcCtD
Dicyclomine—Palpitations—Imiquimod—skin cancer	0.00287	0.0045	CcSEcCtD
Dicyclomine—Loss of consciousness—Imiquimod—skin cancer	0.00286	0.00448	CcSEcCtD
Dicyclomine—Muscular weakness—Temozolomide—skin cancer	0.00285	0.00447	CcSEcCtD
Dicyclomine—Abdominal distension—Temozolomide—skin cancer	0.00281	0.00441	CcSEcCtD
Dicyclomine—Hypertension—Imiquimod—skin cancer	0.00281	0.0044	CcSEcCtD
Dicyclomine—Discomfort—Imiquimod—skin cancer	0.00273	0.00428	CcSEcCtD
Dicyclomine—Dry mouth—Imiquimod—skin cancer	0.00271	0.00424	CcSEcCtD
Dicyclomine—Decreased appetite—Vemurafenib—skin cancer	0.0027	0.00424	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00269	0.00421	CcSEcCtD
Dicyclomine—Fatigue—Vemurafenib—skin cancer	0.00268	0.0042	CcSEcCtD
Dicyclomine—Constipation—Vemurafenib—skin cancer	0.00266	0.00417	CcSEcCtD
Dicyclomine—Oedema—Imiquimod—skin cancer	0.00265	0.00416	CcSEcCtD
Dicyclomine—Lightheadedness—Docetaxel—skin cancer	0.00265	0.00415	CcSEcCtD
Dicyclomine—Hypoaesthesia—Bleomycin—skin cancer	0.00264	0.00414	CcSEcCtD
Dicyclomine—Muscular weakness—Fluorouracil—skin cancer	0.00263	0.00412	CcSEcCtD
Dicyclomine—Shock—Imiquimod—skin cancer	0.00261	0.00409	CcSEcCtD
Dicyclomine—Nervous system disorder—Imiquimod—skin cancer	0.0026	0.00408	CcSEcCtD
Dicyclomine—Tachycardia—Imiquimod—skin cancer	0.00259	0.00406	CcSEcCtD
Dicyclomine—Erectile dysfunction—Temozolomide—skin cancer	0.00258	0.00403	CcSEcCtD
Dicyclomine—Anorexia—Imiquimod—skin cancer	0.00253	0.00396	CcSEcCtD
Dicyclomine—Thrombophlebitis—Docetaxel—skin cancer	0.00249	0.00389	CcSEcCtD
Dicyclomine—Insomnia—Imiquimod—skin cancer	0.0024	0.00376	CcSEcCtD
Dicyclomine—Paraesthesia—Imiquimod—skin cancer	0.00238	0.00373	CcSEcCtD
Dicyclomine—Dyspnoea—Imiquimod—skin cancer	0.00237	0.00371	CcSEcCtD
Dicyclomine—Somnolence—Imiquimod—skin cancer	0.00236	0.00369	CcSEcCtD
Dicyclomine—Dyspepsia—Imiquimod—skin cancer	0.00234	0.00366	CcSEcCtD
Dicyclomine—Erythema—Bleomycin—skin cancer	0.00231	0.00362	CcSEcCtD
Dicyclomine—Decreased appetite—Imiquimod—skin cancer	0.00231	0.00361	CcSEcCtD
Dicyclomine—Hypersensitivity—Vemurafenib—skin cancer	0.00229	0.00359	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00229	0.00359	CcSEcCtD
Dicyclomine—Fatigue—Imiquimod—skin cancer	0.00229	0.00358	CcSEcCtD
Dicyclomine—Pain—Imiquimod—skin cancer	0.00227	0.00355	CcSEcCtD
Dicyclomine—Asthenia—Vemurafenib—skin cancer	0.00223	0.0035	CcSEcCtD
Dicyclomine—Hallucination—Temozolomide—skin cancer	0.00223	0.00349	CcSEcCtD
Dicyclomine—Hypoaesthesia—Temozolomide—skin cancer	0.00223	0.00349	CcSEcCtD
Dicyclomine—Pruritus—Vemurafenib—skin cancer	0.0022	0.00345	CcSEcCtD
Dicyclomine—Lethargy—Docetaxel—skin cancer	0.0022	0.00344	CcSEcCtD
Dicyclomine—Feeling abnormal—Imiquimod—skin cancer	0.00219	0.00342	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Imiquimod—skin cancer	0.00217	0.0034	CcSEcCtD
Dicyclomine—Erythema—Dactinomycin—skin cancer	0.00215	0.00337	CcSEcCtD
Dicyclomine—Ill-defined disorder—Bleomycin—skin cancer	0.00214	0.00336	CcSEcCtD
Dicyclomine—Urticaria—Imiquimod—skin cancer	0.00211	0.0033	CcSEcCtD
Dicyclomine—Abdominal pain—Imiquimod—skin cancer	0.0021	0.00329	CcSEcCtD
Dicyclomine—Eye disorder—Temozolomide—skin cancer	0.00209	0.00328	CcSEcCtD
Dicyclomine—Malaise—Bleomycin—skin cancer	0.00208	0.00326	CcSEcCtD
Dicyclomine—Cardiac disorder—Temozolomide—skin cancer	0.00208	0.00325	CcSEcCtD
Dicyclomine—Dizziness—Vemurafenib—skin cancer	0.00206	0.00322	CcSEcCtD
Dicyclomine—Hypoaesthesia—Fluorouracil—skin cancer	0.00205	0.00321	CcSEcCtD
Dicyclomine—Immune system disorder—Temozolomide—skin cancer	0.00202	0.00317	CcSEcCtD
Dicyclomine—Mediastinal disorder—Temozolomide—skin cancer	0.00202	0.00316	CcSEcCtD
Dicyclomine—Ill-defined disorder—Dactinomycin—skin cancer	0.002	0.00313	CcSEcCtD
Dicyclomine—Vomiting—Vemurafenib—skin cancer	0.00198	0.0031	CcSEcCtD
Dicyclomine—Rash—Vemurafenib—skin cancer	0.00196	0.00307	CcSEcCtD
Dicyclomine—Mental disorder—Temozolomide—skin cancer	0.00196	0.00307	CcSEcCtD
Dicyclomine—Dermatitis—Vemurafenib—skin cancer	0.00196	0.00307	CcSEcCtD
Dicyclomine—Hypersensitivity—Imiquimod—skin cancer	0.00195	0.00306	CcSEcCtD
Dicyclomine—Headache—Vemurafenib—skin cancer	0.00195	0.00305	CcSEcCtD
Dicyclomine—Erythema—Temozolomide—skin cancer	0.00195	0.00305	CcSEcCtD
Dicyclomine—Breast disorder—Docetaxel—skin cancer	0.00194	0.00305	CcSEcCtD
Dicyclomine—Discomfort—Bleomycin—skin cancer	0.00194	0.00304	CcSEcCtD
Dicyclomine—Malaise—Dactinomycin—skin cancer	0.00194	0.00304	CcSEcCtD
Dicyclomine—Asthenia—Imiquimod—skin cancer	0.0019	0.00298	CcSEcCtD
Dicyclomine—Confusional state—Bleomycin—skin cancer	0.0019	0.00298	CcSEcCtD
Dicyclomine—Anaphylactic shock—Bleomycin—skin cancer	0.00189	0.00295	CcSEcCtD
Dicyclomine—Oedema—Bleomycin—skin cancer	0.00189	0.00295	CcSEcCtD
Dicyclomine—Pruritus—Imiquimod—skin cancer	0.00188	0.00294	CcSEcCtD
Dicyclomine—Nausea—Vemurafenib—skin cancer	0.00185	0.00289	CcSEcCtD
Dicyclomine—Vision blurred—Temozolomide—skin cancer	0.00184	0.00288	CcSEcCtD
Dicyclomine—Discomfort—Dactinomycin—skin cancer	0.00181	0.00284	CcSEcCtD
Dicyclomine—Ill-defined disorder—Temozolomide—skin cancer	0.00181	0.00283	CcSEcCtD
Dicyclomine—Anorexia—Bleomycin—skin cancer	0.0018	0.00281	CcSEcCtD
Dicyclomine—Erythema—Fluorouracil—skin cancer	0.0018	0.00281	CcSEcCtD
Dicyclomine—Agitation—Temozolomide—skin cancer	0.00179	0.0028	CcSEcCtD
Dicyclomine—Angioedema—Temozolomide—skin cancer	0.00178	0.00279	CcSEcCtD
Dicyclomine—Oedema—Dactinomycin—skin cancer	0.00176	0.00275	CcSEcCtD
Dicyclomine—Malaise—Temozolomide—skin cancer	0.00176	0.00275	CcSEcCtD
Dicyclomine—Dizziness—Imiquimod—skin cancer	0.00175	0.00275	CcSEcCtD
Dicyclomine—Palpitations—Temozolomide—skin cancer	0.00172	0.0027	CcSEcCtD
Dicyclomine—Paraesthesia—Bleomycin—skin cancer	0.00169	0.00265	CcSEcCtD
Dicyclomine—Vision blurred—Fluorouracil—skin cancer	0.00169	0.00265	CcSEcCtD
Dicyclomine—Vomiting—Imiquimod—skin cancer	0.00169	0.00264	CcSEcCtD
Dicyclomine—Hypertension—Temozolomide—skin cancer	0.00168	0.00263	CcSEcCtD
Dicyclomine—Dyspnoea—Bleomycin—skin cancer	0.00168	0.00263	CcSEcCtD
Dicyclomine—Anorexia—Dactinomycin—skin cancer	0.00168	0.00262	CcSEcCtD
Dicyclomine—Rash—Imiquimod—skin cancer	0.00167	0.00262	CcSEcCtD
Dicyclomine—Dermatitis—Imiquimod—skin cancer	0.00167	0.00262	CcSEcCtD
Dicyclomine—Headache—Imiquimod—skin cancer	0.00166	0.0026	CcSEcCtD
Dicyclomine—Discomfort—Temozolomide—skin cancer	0.00164	0.00257	CcSEcCtD
Dicyclomine—Decreased appetite—Bleomycin—skin cancer	0.00164	0.00257	CcSEcCtD
Dicyclomine—Dry mouth—Temozolomide—skin cancer	0.00162	0.00254	CcSEcCtD
Dicyclomine—Pain—Bleomycin—skin cancer	0.00161	0.00252	CcSEcCtD
Dicyclomine—Confusional state—Temozolomide—skin cancer	0.0016	0.00251	CcSEcCtD
Dicyclomine—Anaphylactic shock—Temozolomide—skin cancer	0.00159	0.00249	CcSEcCtD
Dicyclomine—Oedema—Temozolomide—skin cancer	0.00159	0.00249	CcSEcCtD
Dicyclomine—Nausea—Imiquimod—skin cancer	0.00158	0.00247	CcSEcCtD
Dicyclomine—Nervous system disorder—Temozolomide—skin cancer	0.00156	0.00244	CcSEcCtD
Dicyclomine—Feeling abnormal—Bleomycin—skin cancer	0.00155	0.00243	CcSEcCtD
Dicyclomine—Decreased appetite—Dactinomycin—skin cancer	0.00153	0.00239	CcSEcCtD
Dicyclomine—Fatigue—Dactinomycin—skin cancer	0.00152	0.00237	CcSEcCtD
Dicyclomine—Anorexia—Temozolomide—skin cancer	0.00152	0.00237	CcSEcCtD
Dicyclomine—Discomfort—Fluorouracil—skin cancer	0.00151	0.00237	CcSEcCtD
Dicyclomine—Pain—Dactinomycin—skin cancer	0.0015	0.00235	CcSEcCtD
Dicyclomine—Urticaria—Bleomycin—skin cancer	0.0015	0.00235	CcSEcCtD
Dicyclomine—Hypoaesthesia—Docetaxel—skin cancer	0.00148	0.00232	CcSEcCtD
Dicyclomine—Confusional state—Fluorouracil—skin cancer	0.00148	0.00231	CcSEcCtD
Dicyclomine—Anaphylactic shock—Fluorouracil—skin cancer	0.00147	0.00229	CcSEcCtD
Dicyclomine—Oedema—Fluorouracil—skin cancer	0.00147	0.00229	CcSEcCtD
Dicyclomine—Feeling abnormal—Dactinomycin—skin cancer	0.00145	0.00227	CcSEcCtD
Dicyclomine—Insomnia—Temozolomide—skin cancer	0.00144	0.00225	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00144	0.00225	CcSEcCtD
Dicyclomine—Nervous system disorder—Fluorouracil—skin cancer	0.00144	0.00225	CcSEcCtD
Dicyclomine—Tachycardia—Fluorouracil—skin cancer	0.00143	0.00224	CcSEcCtD
Dicyclomine—Paraesthesia—Temozolomide—skin cancer	0.00143	0.00224	CcSEcCtD
Dicyclomine—Dyspnoea—Temozolomide—skin cancer	0.00142	0.00222	CcSEcCtD
Dicyclomine—Somnolence—Temozolomide—skin cancer	0.00141	0.00221	CcSEcCtD
Dicyclomine—Dyspepsia—Temozolomide—skin cancer	0.0014	0.00219	CcSEcCtD
Dicyclomine—Anorexia—Fluorouracil—skin cancer	0.0014	0.00219	CcSEcCtD
Dicyclomine—Eye disorder—Docetaxel—skin cancer	0.00139	0.00218	CcSEcCtD
Dicyclomine—Abdominal pain—Dactinomycin—skin cancer	0.00139	0.00218	CcSEcCtD
Dicyclomine—Hypersensitivity—Bleomycin—skin cancer	0.00139	0.00218	CcSEcCtD
Dicyclomine—Decreased appetite—Temozolomide—skin cancer	0.00138	0.00217	CcSEcCtD
Dicyclomine—Cardiac disorder—Docetaxel—skin cancer	0.00138	0.00216	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Temozolomide—skin cancer	0.00137	0.00215	CcSEcCtD
Dicyclomine—Fatigue—Temozolomide—skin cancer	0.00137	0.00215	CcSEcCtD
Dicyclomine—Pain—Temozolomide—skin cancer	0.00136	0.00213	CcSEcCtD
Dicyclomine—Constipation—Temozolomide—skin cancer	0.00136	0.00213	CcSEcCtD
Dicyclomine—Asthenia—Bleomycin—skin cancer	0.00135	0.00212	CcSEcCtD
Dicyclomine—Immune system disorder—Docetaxel—skin cancer	0.00134	0.00211	CcSEcCtD
Dicyclomine—Mediastinal disorder—Docetaxel—skin cancer	0.00134	0.0021	CcSEcCtD
Dicyclomine—Pruritus—Bleomycin—skin cancer	0.00133	0.00209	CcSEcCtD
Dicyclomine—Insomnia—Fluorouracil—skin cancer	0.00133	0.00208	CcSEcCtD
Dicyclomine—Paraesthesia—Fluorouracil—skin cancer	0.00132	0.00206	CcSEcCtD
Dicyclomine—Feeling abnormal—Temozolomide—skin cancer	0.00131	0.00205	CcSEcCtD
Dicyclomine—Dyspnoea—Fluorouracil—skin cancer	0.00131	0.00205	CcSEcCtD
Dicyclomine—Mental disorder—Docetaxel—skin cancer	0.0013	0.00204	CcSEcCtD
Dicyclomine—Somnolence—Fluorouracil—skin cancer	0.0013	0.00204	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Temozolomide—skin cancer	0.0013	0.00204	CcSEcCtD
Dicyclomine—Erythema—Docetaxel—skin cancer	0.0013	0.00203	CcSEcCtD
Dicyclomine—Hypersensitivity—Dactinomycin—skin cancer	0.0013	0.00203	CcSEcCtD
Dicyclomine—Dyspepsia—Fluorouracil—skin cancer	0.00129	0.00202	CcSEcCtD
Dicyclomine—Decreased appetite—Fluorouracil—skin cancer	0.00127	0.00199	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00126	0.00198	CcSEcCtD
Dicyclomine—Urticaria—Temozolomide—skin cancer	0.00126	0.00198	CcSEcCtD
Dicyclomine—Asthenia—Dactinomycin—skin cancer	0.00126	0.00198	CcSEcCtD
Dicyclomine—Abdominal pain—Temozolomide—skin cancer	0.00126	0.00197	CcSEcCtD
Dicyclomine—Pain—Fluorouracil—skin cancer	0.00125	0.00196	CcSEcCtD
Dicyclomine—Feeling abnormal—Fluorouracil—skin cancer	0.00121	0.00189	CcSEcCtD
Dicyclomine—Vomiting—Bleomycin—skin cancer	0.0012	0.00188	CcSEcCtD
Dicyclomine—Rash—Bleomycin—skin cancer	0.00119	0.00186	CcSEcCtD
Dicyclomine—Dermatitis—Bleomycin—skin cancer	0.00119	0.00186	CcSEcCtD
Dicyclomine—Hypersensitivity—Temozolomide—skin cancer	0.00117	0.00184	CcSEcCtD
Dicyclomine—Urticaria—Fluorouracil—skin cancer	0.00116	0.00182	CcSEcCtD
Dicyclomine—Syncope—Docetaxel—skin cancer	0.00116	0.00182	CcSEcCtD
Dicyclomine—Palpitations—Docetaxel—skin cancer	0.00114	0.00179	CcSEcCtD
Dicyclomine—Asthenia—Temozolomide—skin cancer	0.00114	0.00179	CcSEcCtD
Dicyclomine—Loss of consciousness—Docetaxel—skin cancer	0.00114	0.00178	CcSEcCtD
Dicyclomine—CYP1A1—skin epidermis—skin cancer	0.00113	0.122	CbGeAlD
Dicyclomine—Pruritus—Temozolomide—skin cancer	0.00112	0.00176	CcSEcCtD
Dicyclomine—Nausea—Bleomycin—skin cancer	0.00112	0.00175	CcSEcCtD
Dicyclomine—Hypertension—Docetaxel—skin cancer	0.00112	0.00175	CcSEcCtD
Dicyclomine—Vomiting—Dactinomycin—skin cancer	0.00112	0.00175	CcSEcCtD
Dicyclomine—Rash—Dactinomycin—skin cancer	0.00111	0.00174	CcSEcCtD
Dicyclomine—Hypersensitivity—Fluorouracil—skin cancer	0.00108	0.00169	CcSEcCtD
Dicyclomine—Dry mouth—Docetaxel—skin cancer	0.00108	0.00169	CcSEcCtD
Dicyclomine—Confusional state—Docetaxel—skin cancer	0.00107	0.00167	CcSEcCtD
Dicyclomine—Oedema—Docetaxel—skin cancer	0.00106	0.00166	CcSEcCtD
Dicyclomine—Anaphylactic shock—Docetaxel—skin cancer	0.00106	0.00166	CcSEcCtD
Dicyclomine—Dizziness—Temozolomide—skin cancer	0.00105	0.00165	CcSEcCtD
Dicyclomine—Nausea—Dactinomycin—skin cancer	0.00104	0.00164	CcSEcCtD
Dicyclomine—Shock—Docetaxel—skin cancer	0.00104	0.00163	CcSEcCtD
Dicyclomine—Nervous system disorder—Docetaxel—skin cancer	0.00104	0.00162	CcSEcCtD
Dicyclomine—Pruritus—Fluorouracil—skin cancer	0.00104	0.00162	CcSEcCtD
Dicyclomine—Tachycardia—Docetaxel—skin cancer	0.00103	0.00162	CcSEcCtD
Dicyclomine—Vomiting—Temozolomide—skin cancer	0.00101	0.00158	CcSEcCtD
Dicyclomine—Anorexia—Docetaxel—skin cancer	0.00101	0.00158	CcSEcCtD
Dicyclomine—Rash—Temozolomide—skin cancer	0.001	0.00157	CcSEcCtD
Dicyclomine—Dermatitis—Temozolomide—skin cancer	0.001	0.00157	CcSEcCtD
Dicyclomine—Headache—Temozolomide—skin cancer	0.000996	0.00156	CcSEcCtD
Dicyclomine—Dizziness—Fluorouracil—skin cancer	0.000969	0.00152	CcSEcCtD
Dicyclomine—Insomnia—Docetaxel—skin cancer	0.000956	0.0015	CcSEcCtD
Dicyclomine—Paraesthesia—Docetaxel—skin cancer	0.00095	0.00149	CcSEcCtD
Dicyclomine—Nausea—Temozolomide—skin cancer	0.000944	0.00148	CcSEcCtD
Dicyclomine—Dyspnoea—Docetaxel—skin cancer	0.000943	0.00148	CcSEcCtD
Dicyclomine—Somnolence—Docetaxel—skin cancer	0.00094	0.00147	CcSEcCtD
Dicyclomine—Vomiting—Fluorouracil—skin cancer	0.000932	0.00146	CcSEcCtD
Dicyclomine—Dyspepsia—Docetaxel—skin cancer	0.000931	0.00146	CcSEcCtD
Dicyclomine—Rash—Fluorouracil—skin cancer	0.000924	0.00145	CcSEcCtD
Dicyclomine—Dermatitis—Fluorouracil—skin cancer	0.000923	0.00145	CcSEcCtD
Dicyclomine—Decreased appetite—Docetaxel—skin cancer	0.000919	0.00144	CcSEcCtD
Dicyclomine—Headache—Fluorouracil—skin cancer	0.000918	0.00144	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000913	0.00143	CcSEcCtD
Dicyclomine—Fatigue—Docetaxel—skin cancer	0.000912	0.00143	CcSEcCtD
Dicyclomine—Constipation—Docetaxel—skin cancer	0.000904	0.00142	CcSEcCtD
Dicyclomine—Pain—Docetaxel—skin cancer	0.000904	0.00142	CcSEcCtD
Dicyclomine—Feeling abnormal—Docetaxel—skin cancer	0.000871	0.00136	CcSEcCtD
Dicyclomine—Nausea—Fluorouracil—skin cancer	0.00087	0.00136	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Docetaxel—skin cancer	0.000865	0.00135	CcSEcCtD
Dicyclomine—Abdominal pain—Docetaxel—skin cancer	0.000836	0.00131	CcSEcCtD
Dicyclomine—Hypersensitivity—Docetaxel—skin cancer	0.000779	0.00122	CcSEcCtD
Dicyclomine—Asthenia—Docetaxel—skin cancer	0.000759	0.00119	CcSEcCtD
Dicyclomine—Pruritus—Docetaxel—skin cancer	0.000748	0.00117	CcSEcCtD
Dicyclomine—Dizziness—Docetaxel—skin cancer	0.000699	0.0011	CcSEcCtD
Dicyclomine—Vomiting—Docetaxel—skin cancer	0.000672	0.00105	CcSEcCtD
Dicyclomine—Rash—Docetaxel—skin cancer	0.000667	0.00104	CcSEcCtD
Dicyclomine—Dermatitis—Docetaxel—skin cancer	0.000666	0.00104	CcSEcCtD
Dicyclomine—Headache—Docetaxel—skin cancer	0.000662	0.00104	CcSEcCtD
Dicyclomine—Nausea—Docetaxel—skin cancer	0.000628	0.000984	CcSEcCtD
Dicyclomine—CYP1A1—nipple—skin cancer	0.000545	0.0588	CbGeAlD
Dicyclomine—CHRM1—female reproductive system—skin cancer	0.000407	0.0439	CbGeAlD
Dicyclomine—CHRM2—head—skin cancer	0.000373	0.0403	CbGeAlD
Dicyclomine—CYP1A1—epithelium—skin cancer	0.000367	0.0396	CbGeAlD
Dicyclomine—CHRM3—female reproductive system—skin cancer	0.000364	0.0393	CbGeAlD
Dicyclomine—CYP1A1—skin of body—skin cancer	0.000349	0.0377	CbGeAlD
Dicyclomine—CHRM1—head—skin cancer	0.00034	0.0367	CbGeAlD
Dicyclomine—CYP1A1—mammalian vulva—skin cancer	0.000318	0.0343	CbGeAlD
Dicyclomine—CHRM3—head—skin cancer	0.000304	0.0328	CbGeAlD
Dicyclomine—CYP1A1—female reproductive system—skin cancer	0.000273	0.0294	CbGeAlD
Dicyclomine—CYP1A1—head—skin cancer	0.000228	0.0246	CbGeAlD
Dicyclomine—CYP1A1—lymph node—skin cancer	0.000159	0.0172	CbGeAlD
